Comparison of clinical and electrodiagnostic features in B12 deficiency neurological syndromes with and without antiparietal cell antibodies
- 1 February 2007
- journal article
- research article
- Published by Oxford University Press (OUP)
- Vol. 83 (976), 124-127
- https://doi.org/10.1136/pgmj.2006.048132
Abstract
Background and aims: This study was undertaken to compare the clinical and electrodiagnostic (Edx) features in autoimmune and nutritional vitamin B12 deficiency neurological syndromes. Methods: Consecutive patients with vitamin B12 deficiency neurological syndromes were evaluated and blood counts, red blood cell indices, serum chemistry, thyroid function, HIV serology, antiparietal cell antibody (APCA), serum B12, bone marrow and spinal MRI assessed. EDx studies included nerve conduction, tibial somatosensory (SEP) and motor evoked potential (MEP) to the tibialis anterior, and visual evoked potential (VEP). The results were compared between APCA positive and negative groups. Results: 57 patients aged 17–80 years (mean 45.3) were studied; 48 were vegetarians. The presenting clinical syndromes were myeloneuropathy in 25, myelopathy in 14, myeloneuroencephalopathy in 13, myeloencephalopathy in four and behavioural abnormality only in one patient. Spinal MRI in 47 patients revealed posterior spinal cord hyperintensity in 21 and cord atrophy in six. Nerve conduction was abnormal in 15%, MEP in 56.6%, SEP in 87.3% and VEP in 63.6% of patients. At 3 months, 31 patients had complete, 11 partial and three poor recovery. APCA was positive in 49% of patients. There was no difference in clinical, MRI or Edx findings or outcome between the APCA positive and negative groups. Conclusion: APCA was positive in 49% of patients with B12 deficiency neurological syndrome but their clinical, MRI and Edx changes were not different from the APCA negative group. Neurological manifestations may be caused by B12 deficiency itself rather than the underlying cause.Keywords
This publication has 15 references indexed in Scilit:
- Cobalamin (vitamin B12) in subacute combined degeneration and beyond: traditional interpretations and novel theoriesExperimental Neurology, 2005
- Vitamin B12 deficiency neurological syndromes: a clinical, MRI and electrodiagnostic study.2003
- Subacute Combined Degeneration One Century Later. The Neurotrophic Action of Cobalamin (Vitamin B12) RevisitedJournal of Neuropathology and Experimental Neurology, 2001
- Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findingsJournal of Neurology, Neurosurgery & Psychiatry, 1998
- METHYLMALONIC ACID AS A MARKER FOR COBALAMIN DEFICIENCY: FACT OR FANTASY? ELUCIDATIONS FROM THE COBALAMIN‐DEFICIENT RATBritish Journal of Haematology, 1998
- The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalitiesEuropean Journal of Haematology, 1995
- What are the Psychiatric Manifestations of Vitamin B12 Deficiency?Journal of the American Geriatrics Society, 1988
- Neuropsychiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or MacrocytosisNew England Journal of Medicine, 1988
- Effect of Vegetarianism and Smoking on Vitamin B12, Thiocyanate, and Folate Levels in the Blood of Normal SubjectsBMJ, 1972
- Vitamin-B12-Resorption bei der sogenannten Tabak-AmblyopieDeutsche Medizinische Wochenschrift (1946), 1970